Summaries for Patients |

Screening for Type 2 Diabetes in Adults: U.S. Preventive Services Task Force Recommendations FREE

[+] Article, Author, and Disclosure Information

The summary below is from the full reports titled “Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement” and “ Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force.” They are in the 3 June issue of Annals of Internal Medicine (volume 148, pages 846-854 and pages 855-868). The first report was written by the U.S. Preventive Services Task Force; the second report was written by S.L. Norris, D. Kansagara, C. Bougatsos, and R. Fu.

Ann Intern Med. 2008;148(11):I-30. doi:10.7326/0003-4819-148-11-200806030-00001
Text Size: A A A

What is the U.S. Preventive Services Task Force?

The U.S. Preventive Services Task Force (USPSTF) is a group of health experts that reviews published research and makes recommendations about preventive health care.

What is the problem and what is known about it so far?

Diabetes mellitus is a common disease that interferes with the body's ability to store energy from food. The pancreas makes a substance called insulin, which helps to store energy from food. Type 1 diabetes (juvenile diabetes) occurs when the pancreas stops making insulin. In type 2 diabetes (adult-onset diabetes), the body makes plenty of insulin but is unable to use it normally. In both cases, the result is high blood sugar levels. Over time, high blood sugar levels can lead to blindness, kidney failure, nerve damage, and heart disease. Fortunately, good care with diet, exercise, and medications can prevent the development of complications. Good care includes treatment to keep blood sugar levels normal. People with diabetes have more heart attacks and strokes than people without diabetes. Controlling blood pressure and cholesterol helps to prevent these complications. For people with diabetes who also have high blood pressure and cholesterol problems, good care also includes treatment of these conditions. Type 1 diabetes usually does not go long before being diagnosed. However, many people with type 2 diabetes have diabetes for years before symptoms begin.

Testing people who have no symptoms to try to detect disease early is called screening. Screening for diabetes would be helpful only if people who begin treatment before symptoms develop do better than people who start treatment after symptoms develop. Screening for diabetes involves blood tests to look for high blood sugar levels.

How did the USPSTF develop these recommendations?

The USPSTF reviewed published research to measure the benefits and harms of testing for diabetes in people with no symptoms.

What did the USPSTF find?

The USPSTF did not find studies that prove that treating people with normal blood pressure and diabetes to lower blood sugar before they have symptoms leads to fewer diabetes complications (such as heart attacks, strokes, or kidney problems) than if treatment begins when symptoms develop. No studies have looked at the long-term harms of diabetes screening. Short-term harms include worry caused by labeling people as having diabetes and giving them diabetes treatments. However, the USPSTF did find studies that show that people with high blood pressure (>135/80 mm Hg) and diabetes have fewer heart attacks and strokes if blood pressure is lowered below this level.

What does the USPSTF suggest that patients do?

Patients with normal blood pressure (≤135/80 mm Hg) should know that it is unclear whether screening for diabetes would help them. These patients should discuss diabetes screening with their doctors.

Patients with high blood pressure (>135/80 mm Hg) should be screened for diabetes.

What are the cautions related to these recommendations?

These recommendations do not apply to people who have symptoms that might be due to diabetes. Patients with symptoms should be tested for diabetes. The recommendations may change as new studies become available.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.